If you or someone you love is concerned about Alzheimer’s disease, the process of detecting its presence can involve a series ...

An Enquirer analysis found that doctors, nurses and other practitioners received $136 million from pharma and biotech companies from 2017 and 2023.

Japan-based Fujirebio's test, which helps doctors diagnose Alzheimer's disease, is intended for patients with signs of ...

FDA inspections are essential to ensuring the safety and quality of products in the food, pharmaceutical, and medical device industries. One of the experienced professionals in this field is John ...

A decade-long effort to curb illicit drug trafficking in the region was recently buttressed by an investment in new equipment ...

The new test, from Fujirebio Diagnostics, Inc., identifies a sticky brain plaque, known as beta-amyloid, that is a key marker ...

The U.S. Food and Drug Administration on Friday cleared the first blood test for the diagnosis of Alzheimer's disease.

The FDA has approved the first blood test for diagnosing Alzheimer’s disease, which could speed the path to treatment for ...

Boise police found explosive devices during what began as a drug investigation. BPD’s Bomb Squad was called out, and ...

The EnVisio X1 platform is currently under development stage and unavailable for sale or clinical usage in the US.

WASHINGTON, D.C.—FDA Commissioner Martin Makary, M.D., offered more details into the agency’s recently announced plans to ...